Skip to content

Shirodhara as a Therapeutic Intervention in sleeplessness using Lakshadi Tail A Clinical Insight into Sleep Enhancement

A CLINICO-CONCEPTUAL STUDY OF SHIRODHARA WITH LAKSHADI TAIL IN THE MANAGEMENT OF ANIDRA W.S.R. TO Nidra laabhabh sukham - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089359
Enrollment
50
Registered
2025-06-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F439- Reaction to severe stress, unspecified

Interventions

None listed

Sponsors

State Ayurvedic College And Hospital Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Individuals between the age group of 21 to 60 years of both male and female suffering from anidra of minimum one month duration and occurs atleast 3 nights per week will be selected randomly for the study. Patients suffering from disturbed sleep having AIS Score Greater than 6 assessed on Athens insomnia scale. Patient or their parents willing to participate in the trial. Patient having symptoms of Anidra as mentioned in classical texts as well as presenting the complaints of reduction in sleep time, difficulty in initiating or maintaining sleep, Wakefulness during normal sleep, suffering from non-restorative sleep. Patients will be selected irrespective of sex, occupation, caste, religion, etc. who will agree to stop their previous medication.

Exclusion criteria

Exclusion criteria: 1.Patients below 21 years and above 60 years of age. 2. Pregnant lady and lactating mother. 3. Nidranasha due to Abhighata- are excluded because, it is a condition where the pain dominates to induce sleep disturbances. 4. Patient with other systemic disorders, breathing related disorders,hyperthyroidism and major psychiatric illness like schizophrenia,depressive psychosis, epilepsy etc. will not be registered. 5. Patients with alcohol dependency or drug dependency will be excluded from the study. 6. Patients having chronic illness like asthma, malignancies, liver cirrhosis, chronic renal failure, uncontrolled diabetes, Chronic obstructive Pulmonary Disorders and Hypertension etc. will be excluded. 7. Patients with acute illness like CardioVascular Accident, Congestive Cardiac Failure, Myocardial Infarction, acute pain conditions or any Grave disease will be excluded. 8. Patient not willing for consent.

Design outcomes

Primary

MeasureTime frame
To assess the effectiveness of trial drug Lakshadi Tail Shirodhara will be administered in the condition of Anidra for 15 days and efficacy of the drug will be observed and assessed related datas will be collected and analyse and result will be prepared accordinglyTimepoint: 15th Day,30th Day,45th Day,60th Day and 30 days after the trial is completed.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Goldy Singh

P.G. Department of Samhita and Siddhant, State Ayurvedic College and Hospital, Lucknow

hcsinghkushwaha@gmail.com9452591185

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026